Your browser doesn't support javascript.
loading
Morbidity burden of imported chronic schistosomiasis among West African migrants.
Roure, Sílvia; Vallès, Xavier; Pérez-Quílez, Olga; López-Muñoz, Israel; Valerio, Lluís; Soldevila, Laura; Chamorro, Anna; Abad, Elena; Hegazy, Alaa H A; Fernández-Rivas, Gema; Gorriz, Ester; Herena, Dolores; Fernández-Pedregal, Elia; José, Alba San; España-Cueto, Sergio; Paredes, Roger; Miranda-Sánchez, Jose; Miralles, Maria Carme; Conde, Carmen; Montero, Juan José; Núñez-Andrés, Maria Amparo; Llibre, Josep M; Isnard, Mar; Bonet, Josep Maria; Estrada, Oriol; Prat, Núria; Clotet, Bonaventura.
Afiliação
  • Roure S; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain; Fundació Lluita contra les Infeccions, Badalona, Spain; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona,
  • Vallès X; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain; Fundació Lluita contra les Infeccions, Badalona, Spain; Germans Trias i Pujol Research Institute, Badalona, Spain.
  • Pérez-Quílez O; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain.
  • López-Muñoz I; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain.
  • Valerio L; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain.
  • Soldevila L; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain; Fundació Lluita contra les Infeccions, Badalona, Spain; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona,
  • Chamorro A; Fundació Lluita contra les Infeccions, Badalona, Spain.
  • Abad E; Fundació Lluita contra les Infeccions, Badalona, Spain.
  • Hegazy AHA; Germans Trias i Pujol Research Institute, Badalona, Spain; Microbiology Department, Germans Trias i Pujol University Hospital, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Badalona, Spain; Faculty of Medicine, University of Asyut, El Fateh, Egypt.
  • Fernández-Rivas G; Microbiology Department, Germans Trias i Pujol University Hospital, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Gorriz E; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain.
  • Herena D; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain.
  • Fernández-Pedregal E; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain; Fundació Lluita contra les Infeccions, Badalona, Spain; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona,
  • José AS; Fundació Lluita contra les Infeccions, Badalona, Spain.
  • España-Cueto S; International Health Program (PROSICS), Direcció Territorial de Malalties Infeccioses Metropolitana Nord, Institut Català de la Salut, Badalona 08914, Spain; Fundació Lluita contra les Infeccions, Badalona, Spain; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona,
  • Paredes R; Fundació Lluita contra les Infeccions, Badalona, Spain; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Miranda-Sánchez J; North Metropolitan Primary Care Directorate, Institut Català de la Salut, Sabadell, Spain.
  • Miralles MC; Primary Health Care Unit Canovelles, North Metropolitan Health Region from Barcelona, Institut Català de la Salut, Granollers, Spain.
  • Conde C; Primary Health Care Unit Canovelles, North Metropolitan Health Region from Barcelona, Institut Català de la Salut, Granollers, Spain.
  • Montero JJ; Primary Health Care Unit Mataró-3 (Rocafonda-Palau), North Metropolitan Health Region from Barcelona, Institut Català de la Salut, Mataró, Spain.
  • Núñez-Andrés MA; Department of Civil and Environmental Engineering, Universitat Politècnica de Catalunya-BarcelonaTech, Barcelona, Spain.
  • Llibre JM; Fundació Lluita contra les Infeccions, Badalona, Spain; Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Isnard M; North Metropolitan Primary Care Directorate, Institut Català de la Salut, Sabadell, Spain.
  • Bonet JM; North Metropolitan Primary Care Directorate, Institut Català de la Salut, Sabadell, Spain.
  • Estrada O; Directorate for Innovation and Interdisciplinary Cooperation, North Metropolitan Territorial Health Region, Institut Català de la Salut, Badalona, Spain.
  • Prat N; North Metropolitan Primary Care Directorate, Institut Català de la Salut, Sabadell, Spain.
  • Clotet B; Fundació Lluita contra les Infeccions, Badalona, Spain; IrsiCaixa-Institut de Recerca de La SIDA, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Direcció Territorial Malalties Infeccioses, North Metropolitan Territorial Health Region, Institut Català de la Salut, Badalona, Spain.
J Infect ; 89(4): 106234, 2024 Aug 03.
Article em En | MEDLINE | ID: mdl-39098555
ABSTRACT

BACKGROUND:

Past exposure to schistosomiasis is frequent among migrants from endemic countries, and chronic untreated infection may lead to long-term morbidities.

METHODS:

We carried out a prospective population-based cross-sectional study among migrants from endemic Sub-Saharan countries living in Barcelona, Spain. Participants had not been previously diagnosed or treated for schistosomiasis. Clinical signs and symptoms were scrutinised through a systematic revision of electronic medical records and an on-site standardised questionnaire, and blood and urine samples were screened for Schistosoma.

FINDINGS:

We recruited 522 eligible participants, 74.3% males, mean age 42.7 years (SD=11.5, range 18-76), Overall, 46.4% were from Senegal and 23.6% from Gambia. They had lived in the European Union for a median of 16 years (IQR 10-21). The prevalence of a Schistosoma-positive serology was 35.8%. S. haematobium eggs were observed in urine samples in 6 (1.2%) participants. The most prevalent symptoms among Schistosoma-positive participants were chronic abdominal pain (68.8%, OR=1.79; 95%CI 1.2-2.6), eosinophilia (44.9%, OR=2.69; 95%CI 1.8-4.0) and specific symptoms associated with urinary schistosomiasis, like self-reported episodes of haematuria (37.2%; OR=2.47; 95%CI 1.6-3.8), dysuria (47.9%, OR=1.84; 95%CI=1.3-2.7) and current renal insufficiency (13.4%; OR=2.35; 95%CI=1.3-4.3). We found a significant prevalence of gender-specific genital signs and symptoms among females (mainly menstrual disorders) and males (erectile dysfunction and pelvic pain). Individuals typically presented with a multitude of interconnected symptoms, most commonly chronic abdominal pain, which are often disregarded.

CONCLUSIONS:

Despite the lack of urine parasite identification, the high incidence of clinical signs and symptoms strongly correlated with a positive schistosomiasis serology suggests the existence of a heavy clinical burden among long-term West African migrants living for years/decades in the study region. More research is urgently required to determine whether these symptoms are the result of long-term sequelae or a persistent active Schistosoma infection.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Infect Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Infect Ano de publicação: 2024 Tipo de documento: Article